Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article Text

Letter

Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus

https://doi.org/10.1136/ard.2009.109405

Statistics from Altmetric.com

Footnotes

Funding This study was supported by an unrestricted research grant to HtC from AstraZeneca, The Netherlands.
Competing interests None.
Provenance and Peer review Not commissioned; externally peer reviewed.
Ethics approval Approval from the medical and ethical committee of the Slotervaart Hospital and Jan van Breemen Institute (located at the Slotervaart Hospital), Amsterdam.

Read the full text or download the PDF: